UK markets open in 7 hours 43 minutes
NIKKEI 225
38,946.93 -122.75 (-0.31%) HANG SENG
19,220.62 -415.60 (-2.12%) CRUDE OIL
79.06 -0.20 (-0.25%) GOLD FUTURES
2,425.60 -0.30 (-0.01%) DOW
39,872.99 +66.22 (+0.17%) Bitcoin GBP
55,203.91 +77.79 (+0.14%)
AstraZeneca PLC (AZN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 77.11 |
| Open | 77.76 |
| Bid | 79.16 x 500 |
| Ask | 79.22 x 500 |
| Day's range | 77.76 - 79.25 |
| 52-week range | 60.47 - 79.25 |
| Volume | |
| Avg. volume | 5,422,182 |
| Market cap | 245.495B |
| Beta (5Y monthly) | 0.16 |
| PE ratio (TTM) | 39.00 |
| EPS (TTM) | 2.03 |
| Earnings date | 25 Jul 2024 |
| Forward dividend & yield | 1.45 (1.88%) |
| Ex-dividend date | 22 Feb 2024 |
| 1y target est | 82.74 |
ZacksAstraZeneca (AZN) Plans to Generate $80B in Revenues by 2030
AstraZeneca (AZN) targets $80 billion in total revenues by 2030. It expects to launch 20 new medicines.
- Investing.com
Midday movers: Microsoft, Xpeng rise; Palo Alto, Keysight fall
(Updated - May 21, 2024 11:56 AM EDT)
The GuardianAstraZeneca aims to nearly double revenues to $80bn by 2030
UK’s biggest drugmaker says it plans to launch 20 major new medicines before the end of the decade
© 2024 Yahoo. All rights reserved.